Roald/Easl 2025

EASL Congress 2025 – Newsletter of the Romanian Society of Gastroenterology and Hepatology (SRGH)/RoALD

Romania at the Heart of European Hepatology

EASL 2025 – 60 Years of Innovation in Hepatology

The 60th EASL Congress, held in Amsterdam and streamed globally, brought together over 7,600 participants, presented more than 1,900 abstracts, and launched five new clinical guidelines, reaffirming its position as a leading global forum in liver health.

The Opening Ceremony sent a strong message: science must drive action, especially in the area of alcohol-related harm. A high-level panel featuring EASL leadership, WHO Europe, and public health experts marked the launch of the European Alcohol Health Alliance, a significant milestone for policy collaboration across Europe.

 Romania’s Strong and Visible Presence at EASL 2025

Chairs, Invited Speakers & Scientific Leadership

Romanian hepatology was prominently represented in key scientific sessions:

  • Prof. Dr. Liana Gheorghe  Chair, Session: Do’s and Don’ts in the Management of Comorbidities in Cirrhosis
  • Conf. Dr Bogdan Procopet  Chair, Session: Clinical Practice Guidelines: TIPS and Abdominal Surgery; Member of the EASL Scientific Committee
  • Prof. Dr. Andrada Seicean  Speaker, Session: EASL/ESGE/Baveno – The Future of Hepatology: Endohepatology – Expanding Frontiers or a Passing Trend?
    • Talk: The Endosonographic Approach to Diagnosis – Pros and Cons
  • Dr. Speranța Iacob  Speaker, Session: Do’s and Don’ts in Post-Transplant Management: A Crash Course for the General Hepatologist
    • Talk: How to Prevent Long-Term Complications After Liver Transplantation
    • A practical and impactful contribution, highlighting Romania’s expertise in transplant hepatology and multidisciplinary care.

Skills and Knowledge Sharing

Romanian faculty were also involved in hands-on teaching within the EASL/EFSUMB Skills Learning Centre, especially in:

  • Abdominal Sonography
  • FibroScan® Training

Poster Presentations

Romanian Hepatology research teams contributed six accepted posters, showcasing clinical and academic strength:

  • 3 from Fundeni Clinical Institute
  • 2 from Iași
  • 1 from Cluj

Themes included:

  • Viral hepatitis/MASLD
  • Liver fibrosis evaluation
  • Cirrhosis complications
  • Transplant outcomes
  • Integrated care models 

RoALD – Romanian Association for Liver Diseases

A major milestone was the scientific and institutional presence of RoALD at the congress:

  • Poster presentation: Showcased RoALD’s contributions to research, clinical education, and public health
  • Networking: Strengthened European partnerships
  • Recognition: Highlighted RoALD as a model for professional society engagement at the European level 

Patient Representation: A United Voice

Romania was also represented by Marinela Debu, President of APAH-RO. Her presence underscored the essential role of patient organizations in shaping the future of hepatology in Europe. 

Scientific Priorities Aligned with Romanian Interests

Alcohol-Related Liver Disease & Public Health

The launch of the European Alcohol Health Alliance reflects national Romanian priorities and the advocacy work carried out by RoALD and SRGH.

Frontline Research Topics

Romanian institutions are active in several high-priority fields:

  • MASLD biomarkers
  • HBV /HDV cure strategies
  • Artificial intelligence and liquid biopsy in HCC

New EASL Clinical Guidelines with Immediate Relevance

Five new guidelines released at EASL 2025 will directly inform medical practice in Romania:

  • Autoimmune Hepatitis
  • Hepatitis B
  • TIPS
  • Abdominal Surgery in Cirrhosis
  • Cholangiocarcinoma

Romania – A Respected Voice in European Hepatology

EASL Congress 2025 confirmed Romania’s growing role in shaping the future of liver health in Europe — through scientific excellence, strong institutional engagement, and meaningful patient advocacy.

From clinical research and expert training to public health leadership and policy dialogue, the Romanian presence was not only visible (19 Faculty members), but impactful.

Building on the momentum of EASL 2025, we bring back valuable insights, renewed connections, and a shared responsibility to continue advancing hepatology both nationally and across Europe